Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2023-12-27 Sale |
2023-12-28 5:29 pm |
Applied Molecular Transport Inc. | AMTI | Cross Shawn CEO & Chair of the Board |
545,499 | $0 | $0 | 0 (Direct) |
View |
2023-11-22 Sale |
2023-11-24 4:21 pm |
Applied Molecular Transport Inc. | AMTI | Cross Shawn CEO & Chair of the Board |
110,802 | $0.1635 | $18,116 | 545,499 (Direct) |
View |
2023-11-15 Sale |
2023-11-16 5:36 pm |
Applied Molecular Transport Inc. | AMTI | Cross Shawn CEO & Chair of the Board |
90,447 | $0.1606 | $14,526 | 656,301 (Direct) |
View |
2023-06-02 Sale |
2023-10-04 7:27 pm |
Applied Molecular Transport Inc. | AMTI | Cross Shawn CEO & Chair of the Board |
5,559 | $0.23344 | $1,298 | 746,748 (Direct) |
View |
2023-09-29 Sale |
2023-10-02 7:02 pm |
Applied Molecular Transport Inc. | AMTI | Cross Shawn CEO & Chair of the Board |
193,960 | $0.1585 | $30,743 | 752,307 (Direct) |
View |
2023-03-01 Sale |
2023-03-03 5:20 pm |
Applied Molecular Transport Inc. | AMTI | Cross Shawn President & COO |
934 | $0.5 | $467 | 60,156 (Direct) |
View |
2022-12-02 Sale |
2022-12-06 4:56 pm |
Applied Molecular Transport Inc. | AMTI | Cross Shawn President & COO |
3,893 | $1.0501 | $4,088 | 61,090 (Direct) |
View |
2022-09-01 Sale |
2022-09-06 7:17 pm |
Applied Molecular Transport Inc. | AMTI | Cross Shawn President & COO |
884 | $1.4201 | $1,255 | 64,983 (Direct) |
View |
2022-06-01 Sale |
2022-06-03 7:20 pm |
Applied Molecular Transport Inc. | AMTI | Cross Shawn President & COO |
3,933 | $3.009 | $11,834 | 65,867 (Direct) |
View |
2021-08-19 Sale |
2021-08-23 7:40 pm |
Applied Molecular Transport Inc. | AMTI | Cross Shawn Chief Financial Officer |
10,000 | $30.12 | $301,193 | 609,700 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-02-27 Option Award |
2025-03-03 11:44 am |
N/A N/A |
Cyclo Therapeutics Inc. | CYTH | Cross Shawn Director |
28,597 | $0 | 136,346 (Direct) |
View |
2024-11-15 Option Award |
2024-11-18 2:10 pm |
N/A N/A |
Cyclo Therapeutics Inc. | CYTH | Cross Shawn Director |
17,228 | $0 | 107,749 (Direct) |
View |
2024-11-04 Option Award |
2024-11-05 4:42 pm |
N/A 2034-11-04 |
Pacira BioSciences Inc. | PCRX | Cross Shawn Chief Financial Officer |
275,000 | $0 | 275,000 (Direct) |
View |
2024-08-16 Option Award |
2024-08-20 1:49 pm |
N/A N/A |
Cyclo Therapeutics Inc. | CYTH | Cross Shawn Director |
9,028 | $0 | 90,521 (Direct) |
View |
2024-06-03 Option Award |
2024-06-05 5:09 pm |
N/A 2034-06-03 |
Cyclo Therapeutics Inc. | CYTH | Cross Shawn Director |
24,449 | $0 | 97,055 (Direct) |
View |
2023-12-27 Option Award |
2023-12-28 9:50 pm |
2023-12-27 2024-12-27 |
Cyclo Therapeutics Inc. | CYTH | Cross Shawn Director |
161,516 | $0 | 162,516 (Direct) |
View |
Ownership |
2023-12-28 9:48 pm |
N/A N/A |
Cyclo Therapeutics Inc. | CYTH | Cross Shawn Director |
0 | $0 | 0 (Direct) |
View |
2023-09-28 Option Award |
2023-10-02 7:02 pm |
N/A N/A |
Applied Molecular Transport Inc. | AMTI | Cross Shawn CEO & Chair of the Board |
886,111 | $0 | 752,307 (Direct) |
View |
2023-03-24 Option Award |
2023-03-27 9:11 pm |
N/A 2033-03-23 |
Applied Molecular Transport Inc. | AMTI | Cross Shawn CEO & Chair of the Board |
668,000 | $0 | 668,000 (Direct) |
View |
2022-05-16 Option Award |
2022-05-18 6:07 pm |
2022-06-16 2032-05-16 |
Applied Molecular Transport Inc. | AMTI | Cross Shawn President & COO |
102,000 | $0 | 153,750 (Direct) |
View |
2022-02-15 Option Award |
2022-02-16 7:57 pm |
2022-03-15 2032-02-15 |
Applied Molecular Transport Inc. | AMTI | Cross Shawn Chief Financial Officer |
114,750 | $0 | 146,250 (Direct) |
View |
2021-12-24 Option Award |
2022-01-06 7:22 pm |
N/A N/A |
Applied Molecular Transport Inc. | AMTI | Cross Shawn Chief Financial Officer |
31,500 | $0 | 31,500 (Direct) |
View |
2021-08-19 Exercise |
2021-08-23 7:40 pm |
2021-03-12 2030-03-20 |
Applied Molecular Transport Inc. | AMTI | Cross Shawn Chief Financial Officer |
10,000 | $0 | 609,700 (Direct) |
View |
2021-08-19 Exercise |
2021-08-23 7:40 pm |
N/A N/A |
Applied Molecular Transport Inc. | AMTI | Cross Shawn Chief Financial Officer |
10,000 | $4.61 | 609,700 (Direct) |
View |
2021-03-01 Option Award |
2021-03-03 7:00 pm |
2021-04-01 2031-03-01 |
Applied Molecular Transport Inc. | AMTI | Cross Shawn Chief Financial Officer |
63,000 | $0 | 63,000 (Direct) |
View |